| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/25/2002 | CN1370523A Salmon calcitonin snuff and its prepn |
| 09/25/2002 | CN1370522A Method of producing penetrating pump capsule as one new dosage form |
| 09/25/2002 | CN1370429A Health food |
| 09/25/2002 | CN1091383C Process for powdered medicine from natural plant medicated bath liquid |
| 09/25/2002 | CN1091378C Changtong inflammation relieving and pain-stopping oral liquor |
| 09/25/2002 | CN1091377C Labor inducing oral liquid and preparing process thereof |
| 09/25/2002 | CN1091371C Skin nursing cream for curing comedo |
| 09/25/2002 | CN1091369C Ointment for treating face mite disease |
| 09/25/2002 | CN1091367C Vanilla ointment matrix |
| 09/24/2002 | WO2001072289A2 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof |
| 09/24/2002 | US6455592 Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions |
| 09/24/2002 | US6455588 Compositions including modafinil for treatment of eating disorders and for appetite stimulation |
| 09/24/2002 | US6455586 Human contact sensitizers; vehicles consisting of non-volatile, nonionic surfactants and esters of isopropyl alcohol and myristic acid and palmitic acid |
| 09/24/2002 | US6455583 Method for treating meibomian gland disease |
| 09/24/2002 | US6455574 Administering a combinations of amlodipine or a pharmaceutically acceptable acid addition salt thereof and atorvastatin or a pharmaceutically acceptable salt thereof for treatment of combined hypertension and hyperlipidemia |
| 09/24/2002 | US6455568 Combination therapy for inhibiting sphincter incontinence |
| 09/24/2002 | US6455565 Method for inhibiting skin lesion formation using histamine as the active ingredient |
| 09/24/2002 | US6455557 Method of reducing somnolence in patients treated with tizanidine |
| 09/24/2002 | US6455547 Method for treating pharmaceutical compositions |
| 09/24/2002 | US6455533 Substituted benzhydrylpiperazines such as cetirizine, hydroxyzine, efletirizine, meclizine and buclizine, the optically active isomers thereof and the pharmaceutically acceptable salts thereof. |
| 09/24/2002 | US6455526 Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same |
| 09/24/2002 | US6455524 Medicament compositions based on anticholinergically-effective compounds and beta-mimetics |
| 09/24/2002 | US6455518 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-O-(2-hydroxyethyl)-rapamycin |
| 09/24/2002 | US6455517 For therapy of conditions or diseases that are estrogen-dependent, i.e., are estrogen-induced or estrogen-stimulated |
| 09/24/2002 | US6455277 Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides |
| 09/24/2002 | US6455269 Method for localized administration of fibrinolytic metalloproteinases |
| 09/24/2002 | US6455088 Peptide/lipid complex formation by co-lyophilization |
| 09/24/2002 | US6455080 Producing a chewing gum, as well as the chewing gum so produced, includes incorporating a modified release acyclic carboxamide into the gum composition. in one embodiment an acyclic carboxamide is made in a modified release structure |
| 09/24/2002 | US6455078 Grinding and mixing the plant of diffuse hedyotis, dried rhizome of bistort rhizome, giant knotweed rhizome, dried ripe fruit of chinese magnoliviavine fruit to form mixture, boiling in water, filtering and concentrating the extract |
| 09/24/2002 | US6455076 Formulations and methods for reducing skin irritation |
| 09/24/2002 | US6455074 Methods of forming and using the device for the sustained release of an active agent. the improved method of the invention for forming a polymer-based sustained release device comprises forming a polymer/active agent solution by mixing a |
| 09/24/2002 | US6455073 Reagents and methods for specifically delivering antibiotic, antimicrobial and antiviral compounds, drugs and agents to phagocytic mammalian cells. the invention also relates to specific delivery to and uptake of such compounds by |
| 09/24/2002 | US6455069 Directly compressible starch as enhancer of properties of excipients when used as binder and disintegrant for compression tablets |
| 09/24/2002 | US6455068 Chewable dietary fiber tablet or wager comprising, as a source of dietary fiber, a water-soluble, on-gelling inulin having a degree of polymerization of between 2 to 20, wherein the inulin is present in an amount of at least 50% by weight of |
| 09/24/2002 | US6455067 Alkyl-pyrrolidone 0.5-10 weight %, hydrophilic polyalkylene glycol 1-15 weight %, hydrophilic nonionic surfactant 0.01-3 weight %, water soluble polymer having carboxyl group 2-15 weight %, water soluble vinyl polymer 0.1-10 weight %, water |
| 09/24/2002 | US6455066 Intradermal-penetration agents for topical local anesthetic administration |
| 09/24/2002 | US6455065 A flexible moisture-containing hydrophilic hydrogel patch that includes a backing such as paper, cloth or plastic and wate based hydrogel layer |
| 09/24/2002 | US6455064 A kit for delivering a medicament to a patient, comprising a package containing: a container with drugs, catalysts and monomer |
| 09/24/2002 | US6455062 An implantable device for providing systemic or local release of a therapeutic agent in tissue, the device comprising: therapeutic agent; an implant sized for insertion into tissue in which systemic or local release of the therapeutic agent |
| 09/24/2002 | US6455061 Mixture containing n-acetylcysteine, lysine hydrochloride, 2-amino-2-deoxyglucose and magnesium compound |
| 09/24/2002 | US6455053 Quickly soluble solid preparations |
| 09/24/2002 | US6455052 A composition for forming an enteric coating on a tablet, capsule or pellet for oral ingestion includes a liquid mixture of alginic acid particles gelatine, vegetable hydrocolloids and/or animal protein. |
| 09/24/2002 | US6455030 The sheet pressure-sensitive adhesive layer containing a medicine; water insolubility; surface anesthesia, dentistry |
| 09/24/2002 | US6455028 Bronchodilator aerosol, propellant |
| 09/24/2002 | US6455024 Particles of an inorganic material containing a radionuclide and having a specified particle size in microns; radiotherapy |
| 09/24/2002 | US6454759 Microfabricated injectable drug delivery system |
| 09/24/2002 | US6453608 Gellan gum seed coating |
| 09/24/2002 | CA2404322A1 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof |
| 09/24/2002 | CA2106683C Inactivating enveloped viruses and sperm |
| 09/24/2002 | CA2105282C Preparation of factor ix |
| 09/24/2002 | CA2083161C Branched polyanhydrides |
| 09/24/2002 | CA2039477C Parenterally administrable liposome formulation comprising synthetic lipids |
| 09/22/2002 | CA2378038A1 Cicatrizant hydrocolloidal patch containing hyaluronic acid and chondroitin sulphate |
| 09/20/2002 | CA2377453A1 Method of preventing retinopathy of prematurity in a neonate |
| 09/19/2002 | WO2002072870A2 Dry solid medium for storage and analysis of genetic material |
| 09/19/2002 | WO2002072813A1 Monochromatic fluid treatment systems |
| 09/19/2002 | WO2002072766A2 Induction of tumor immunity by variants of folate binding protein |
| 09/19/2002 | WO2002072723A2 Gelatin manufacturing process and product |
| 09/19/2002 | WO2002072722A1 Film coating material |
| 09/19/2002 | WO2002072687A2 Physical forms of clarified hydrocolloids of undiminished properties and method of producing same |
| 09/19/2002 | WO2002072662A1 Method for producing polyesters from hydroxycarboxylic acids and polyols by polycondensation |
| 09/19/2002 | WO2002072636A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 09/19/2002 | WO2002072606A2 Epitope testing using hla |
| 09/19/2002 | WO2002072600A2 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 09/19/2002 | WO2002072594A1 Branched cyclic tetrassacharide, process for producing the same, and use |
| 09/19/2002 | WO2002072448A1 Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein |
| 09/19/2002 | WO2002072178A1 Method and apparatus to control drug therapy dosages in an implantable pump |
| 09/19/2002 | WO2002072166A1 Compositions for drug delivery |
| 09/19/2002 | WO2002072164A1 Hydrocolloid compositions |
| 09/19/2002 | WO2002072152A1 Gene carriers with the use of polysaccharide and process for producing the same |
| 09/19/2002 | WO2002072150A2 Micellar drug delivery vehicles and uses thereof |
| 09/19/2002 | WO2002072149A1 Methods for reducing fat by administration of adiponectin |
| 09/19/2002 | WO2002072135A1 LIQUID INTERFERON α PREPARATIONS FOR INJECTION AND METHOD OF STABILIZING THE SAME |
| 09/19/2002 | WO2002072124A1 Composition containing asiasari radix extracts for protecting brain cells and improving memory |
| 09/19/2002 | WO2002072120A1 Compositions comprising matrine and dictamnine for treating or preventing cancer and other diseases |
| 09/19/2002 | WO2002072118A1 Process for obtention of decoctions of vitis labrusca and vitis vinifera skins |
| 09/19/2002 | WO2002072111A1 Telithromycin suspension with a masked taste |
| 09/19/2002 | WO2002072108A1 Use of fluticasone propionate in the treatment of diseases ameliorated by enhancement of epithelial/matrix adhesion such as asthma, cystic fibrosis and influenza |
| 09/19/2002 | WO2002072107A1 Topical composition containing hydrocortisone |
| 09/19/2002 | WO2002072102A1 Taste masked liquid pharmaceutical compositions |
| 09/19/2002 | WO2002072100A2 Pharmaceutical composition containing pde v inhibitors and surfactants |
| 09/19/2002 | WO2002072095A2 Tiotropium salts for treating inflammatory diseases |
| 09/19/2002 | WO2002072081A1 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same |
| 09/19/2002 | WO2002072080A2 Paracetamol solutions which are stable in storage and ready for infusion |
| 09/19/2002 | WO2002072076A1 Microparticles for hemostasis |
| 09/19/2002 | WO2002072075A1 Oral peptide pharmaceutical dosage form and method of production |
| 09/19/2002 | WO2002072074A1 Method to prepare microparticles metoprolol that contain |
| 09/19/2002 | WO2002072073A2 Pharmaceutical formulation comprising atorvastatin calcium |
| 09/19/2002 | WO2002072072A2 Granules and granules coated with a masked taste |
| 09/19/2002 | WO2002072071A1 Method to obtain microparticles containing a h+, k+ -atp-ase inhibitor |
| 09/19/2002 | WO2002072070A1 Method to obtain microparticles containing a h+, k+-atp-ase inhibitor |
| 09/19/2002 | WO2002072069A1 Novel tablets and capsules and a process for its preparation |
| 09/19/2002 | WO2002072068A2 Lipids, lipid compositions, liposomes, and lipoplexes |
| 09/19/2002 | WO2002072067A2 Pharmaceutical aerosol formulation |
| 09/19/2002 | WO2002072066A1 Composition for rectal delivery of an oxazolidinone antibacterial drug |
| 09/19/2002 | WO2002072065A1 Topical application for treating toenail fungus |
| 09/19/2002 | WO2002072064A2 Granular composition comprising an active compound and a cellulose ether and the use thereof |
| 09/19/2002 | WO2002072052A2 Skin care products with improved skin and material softness |
| 09/19/2002 | WO2002072047A2 Cosmetic or pharmaceutical agent |
| 09/19/2002 | WO2002072037A1 Topical dermal anaesthetic |